MDMA and Psilocybin Regulate Oligodendrocyte-Lineage Cell Numbers and Anxiety-Like Behaviors in a Rat Model of Fear
No abstract is available for this record.
Bibliographic context
- Journal
- Biological Psychiatry
- Date
- 2026-01-31
- Source
- OpenAlex
- PubMed
- 41644029
Authors
Watch authorTopics and keywords
psilocybin AnxietyPharmacologyReceptor PharmacologyAnimal StudyToxicity Animal Study PsilocybinMDMARat modelHallucinogenNeurosciencePharmacologyOligodendrocytePsychologyPyramidal cellMyelinAmygdalaSerotoninMedicineMethamphetamineFreezing behaviorCellImipramineHippocampusPsychedelics and Drug StudiesForensic Toxicology and Drug Analysis
Citation graph
0 referenced DOIs found in stored source metadata. 1 indexed paper cite this DOI.
Indexed papers citing this DOI
Related papers
Psilocybin restores behavior and 5-HT2A signaling while reducing microglial density after chronic traumatic brain injury in ratsCell Reports Medicine · 2026-05-31Blocking 5-HT2B receptors abolishes psilocybin’s efficacy in the rat forced swim testJournal of Psychopharmacology · 2026-06-22The Use of Psilocybin for Managing Refractory Behavioral Health Conditions: A New and Promising ApproachDigital Showcase Research, Scholarship, & Creative Works (University of Lynchburg) · 2026-05-21Corrigendum to “From Prohibited to Prescribed: The Rescheduling of MDMA and Psilocybin in Australia”Drug Science Policy and Law · 2026-05-31Psilocybin for Treatment-Resistant Depression: A Comprehensive Review of Mechanisms and Therapeutic PotentialDigital Showcase Research, Scholarship, & Creative Works (University of Lynchburg) · 2026-05-21Rapid-acting interventions in treatment-resistant depression - a comparative review of esketamine and psilocybinJournal of Pre-Clinical and Clinical Research · 2026-05-11PDE4B Inhibition and Psilocybin as Promising Approaches for Treating Methamphetamine Use Disorder: Preclinical Evidence From Rat Models (Abstract ID: 232554)Journal of Pharmacology and Experimental Therapeutics · 2026-04-30Psilocybin-assisted therapy in treatment-resistant depression: rapid remission, uncertain durability, and the next phase of clinical evidenceAnnals of Medicine and Surgery · 2026-06-17